Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Open accessAbstract
Aptamers are short, single-stranded oligonucleotides that bind to specific target molecules. The shape-forming feature of single-stranded oligonucleotides provides high affinity and excellent specificity toward targets. Hence, aptamers can be used as analogs of antibodies. In December 2004, the US Food and Drug Administration approved the first aptamer-based therapeutic, pegaptanib (Macugen), targeting vascular endothelial growth factor, for the treatment of age-related macular degeneration. Since then, however, no aptamer medication for public health has appeared. During these relatively silent years, many trials and improvements of aptamer therapeutics have been performed, opening multiple novel directions for the therapeutic application of aptamers. This review summarizes the basic characteristics of aptamers and the chemical modifications available for aptamer therapeutics.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Targeting RNAs has become an opportunity to therapeutically modulate cellular processes linked to previously undruggable protein targets.
“With the increasing recognition of the vital role played by RNA in transferring cellular information and regulating genes, targeting RNAs has become an exciting opportunity to therapeutically modulate cellular processes linked to previously “undruggable” protein targets.550–552”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [552]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404 · see citing works
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,421 · see citing works
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,845 · see citing works
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 2× · see citing works
“reported that sgRNA has loop regions outside of Cas9, and a natural RNA aptamer could be integrated [92].”
BackgroundTherapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,189 · see citing works
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754 · see citing works
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,591 · see citing works
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,539 · see citing works
Deisenhofer, J. (1981) · PubMed · Cited by 1,422 · see citing works
Ruckman, J., Green, L. S., Beeson, J., Waugh, S. M., Gillette, W. L., Henninger, D. D., Claesson, L., & Janjić, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744 · see citing works
Synthetic genetic polymers capable of heredity and evolution
Pinheiro, V. B., Taylor, A. I., Cozens, C., Abramov, M., Renders, M., Zhang, S., Chaput, J. C., Wengel, J., Peak-Chew, S.-Y., McLaughlin, S. H., et al. (2012) · Science · doi:10.1126/science.1217622 · Cited by 730 · see citing works
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Kimoto, M., Yamashige, R., Matsunaga, K., Yokoyama, S., & Hirao, I. (2013) · Nature Biotechnology · doi:10.1038/nbt.2556 · Cited by 511 · see citing works
Hachimoji DNA and RNA: A genetic system with eight building blocks.
Hoshika, S., Leal, N. A., Kim, M.-J., Kim, M.-S., Karalkar, N. B., Kim, H.-J., Bates, A. M., Watkins, N. E., SantaLucia, H. A., Meyer, A. J., et al. (2019) · Science · doi:10.1126/science.aat0971 · Cited by 494 · see citing works
Albumin as a versatile platform for drug half-life extension
Sleep, D., Cameron, J., & Evans, L. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.023 · Cited by 490 · see citing works
Mirror-image RNA that binds D-adenosine
Klußmann, S., Nolte, A., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1112 · Cited by 397 · see citing works
Reyes‐Reyes, E. M., Teng, Y., & Bates, P. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0920 · Cited by 389 · see citing works
Modified deoxyoligonucleotides stable to exonuclease degradation in serum
Shaw, J., Kent, K. M., Bird, J., Fishback, J. A., & Froehler, B. C. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.4.747 · Cited by 370 · see citing works
Cummins, L. L., Owens, S. R., Risen, L. M., Lesnik, E. A., Freier, S., McGee, D. P. C., Guinosso, C. J., & Cook, P. D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.11.2019 · Cited by 364 · see citing works
Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF
Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 346 · see citing works
CENTROIDFOLD: a web server for RNA secondary structure prediction
Sato, K., Hamada, M., Asai, K., & Mitsuyama, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp367 · Cited by 334 · see citing works
In vitro selection with artificial expanded genetic information systems
Sefah, K., Yang, Z., Bradley, K. M., Hoshika, S., Jiménez, E., Zhang, L., Zhu, G., Shanker, S., Yu, F., Turek, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311778111 · Cited by 330 · see citing works
A mutant T7 RNA polymerase as a DNA polymerase.
Sousa, R., & Padilla, R. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00140.x · Cited by 288 · see citing works
Sheddable Ternary Nanoparticles for Tumor Acidity-Targeted siRNA Delivery
Yang, X., Du, J., Dou, S., Mao, C., Long, H., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn204240b · Cited by 284 · see citing works
A tripeptide ‘anticodon’ deciphers stop codons in messenger RNA
Ito, K., Uno, M., & Nakamura, Y. (2000) · Nature · doi:10.1038/35001115 · Cited by 284 · see citing works
Self-citationAlam, K. K., Chang, J. L., & Burke, D. H. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.4 · Cited by 264 · see citing works
Davies, D. R., Gelinas, A. D., Zhang, C., Rohloff, J. C., Carter, J. D., O’Connell, D., Waugh, S. M., Wolk, S. K., Mayfield, W. S., Burgin, A. B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213933109 · Cited by 257 · see citing works
Selection of DNA Aptamers That Recognize α-Synuclein Oligomers Using a Competitive Screening Method
Tsukakoshi, K., Abe, K., Sode, K., & Ikebukuro, K. (2012) · Analytical Chemistry · doi:10.1021/ac300330g · Cited by 211 · see citing works
A synthetic molecular system capable of mirror-image genetic replication and transcription
Wang, Z., Xu, W., Liu, L., & Zhu, T. F. (2016) · Nature Chemistry · doi:10.1038/nchem.2517 · Cited by 209 · see citing works
Mirror-design of L-oligonucleotide ligands binding to L-arginine
Nolte, A., Klußmann, S., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1116 · Cited by 206 · see citing works
Embracing proteins: structural themes in aptamer–protein complexes
Gelinas, A. D., Davies, D. R., & Janjić, N. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.01.009 · Cited by 206 · see citing works
Rhie, A., Kirby, L., Sayer, N. M., Wellesley, R., Disterer, P., Sylvester, I., Gill, A. C., Hope, J., James, W., & Tahiri‐Alaoui, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305297200 · Cited by 184 · see citing works
Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer
Dollins, C. M., Nair, S. K., Boczkowski, D., Lee, J., Layzer, J. M., Gilboa, E., & Sullenger, B. A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.05.016 · Cited by 183 · see citing works
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 182 · see citing works
Highly specific unnatural base pair systems as a third base pair for PCR amplification
Yamashige, R., Kimoto, M., Takezawa, Y., Sato, A., Mitsui, T., Yokoyama, S., & Hirao, I. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1068 · Cited by 170 · see citing works
Carlson-Stevermer, J., Abdeen, A. A., Kohlenberg, L., Goedland, M., Molugu, K., Lou, M., & Saha, K. (2017) · Nature Communications · doi:10.1038/s41467-017-01875-9 · Cited by 170 · see citing works
Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth
Mahlknecht, G., Maron, R., Mancini, M., Schechter, B., Sela, M., & Yarden, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302594110 · Cited by 169 · see citing works
Crystal structure of NF-κB (p50) 2 complexed to a high-affinity RNA aptamer
Huang, D.-B., Vu, D., Cassiday, L. A., Zimmerman, J. M., Maher, L. J., & Ghosh, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1632011100 · Cited by 167 · see citing works
Crystal structure of an RNA aptamer bound to thrombin
Long, S. B., Long, M. B., White, R. R., & Sullenger, B. A. (2008) · RNA · doi:10.1261/rna.1239308 · Cited by 156 · see citing works
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B. T., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C. J., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980200o · Cited by 146 · see citing works
Gaus, H. J., Gupta, R., Chappell, A. E., Østergaard, M. E., Swayze, E. E., & Seth, P. P. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1260 · Cited by 144 · see citing works
Evolution of thermophilic DNA polymerases for the recognition and amplification of C2ʹ-modified DNA
Chen, T., Hongdilokkul, N., Liu, Z., Adhikary, R., Tsuen, S. S., & Romesberg, F. E. (2016) · Nature Chemistry · doi:10.1038/nchem.2493 · Cited by 143 · see citing works
A mutation in T7 RNA polymerase that facilitates promoter clearance
Guillerez, J., Lopez, P. J., Proux, F., Launay, H. M. M., & Dreyfus, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407141102 · Cited by 139 · see citing works
Oligonucleotide‐Based Mimetics of Hepatocyte Growth Factor
Ueki, R., Ueki, A., Kanda, N., & Sando, S. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508572 · Cited by 139 · see citing works
Vater, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng130 · Cited by 135 · see citing works
The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation
Chen, L., Rashid, F., Shah, A., Awan, H. M., Wu, M., Liu, A., Wang, J., Zhu, T., Luo, Z., & Shan, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502159112 · Cited by 128 · see citing works
Griffiths, A. D., POTTER, B. V. L., & Eperon, I. C. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.10.4145 · Cited by 127 · see citing works
Aurup, H., Tuschl, T., Benseler, F., Ludwig, J., & Eckstein, F. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.1.20 · Cited by 126 · see citing works
Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells
Kotula, J. W., Pratico, E. D., Ming, X., Nakagawa, O., Juliano, R. L., & Sullenger, B. A. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0347 · Cited by 120 · see citing works
Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G
Miyakawa, S., Nomura, Y., Sakamoto, T., Yamaguchi, Y., Kato, K., Yamazaki, S., & Nakamura, Y. (2008) · RNA · doi:10.1261/rna.1005808 · Cited by 118 · see citing works
Self-citationSelection and Characterization of an RNA Decoy for Transcription Factor NF-κB
Lebruska, L. L., & Maher, L. J. (1999) · Biochemistry · doi:10.1021/bi982515x · Cited by 117 · see citing works
Müller, J., Freitag, D. F., Mayer, G., & Pötzsch, B. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03162.x · Cited by 115 · see citing works
CRISPR-mediated Activation of Latent HIV-1 Expression
Limsirichai, P., Gaj, T., & Schaffer, D. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.213 · Cited by 109 · see citing works
Lee, C. H., Lee, S.-H., Kim, J. H., Noh, Y.-H., Noh, G., & Lee, S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.30 · Cited by 106 · see citing works
Mechanism of Ribose 2‘-Group Discrimination by an RNA Polymerase
Huang, Y., Eckstein, F., Padilla, R. M., & Sousa, R. (1997) · Biochemistry · doi:10.1021/bi962674l · Cited by 104 · see citing works
Nomura, Y., Sugiyama, S., Sakamoto, T., Miyakawa, S., Adachi, H., Takano, K., Murakami, S., Tsuyoshi Inoue, A., Mori, Y., Nakamura, Y., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq615 · Cited by 103 · see citing works
Self-citationNew NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEX
Kato, Y., Minakawa, N., Komatsu, Y., Kamiya, H., Ogawa, N., Harashima, H., & Matsuda, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki578 · Cited by 101 · see citing works
Bioinformatic Analysis of the Contribution of Primer Sequences to Aptamer Structures
Cowperthwaite, M. C., & Ellington, A. D. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9130-4 · Cited by 100 · see citing works
Novel Combinatorial Selection of Phosphorothioate Oligonucleotide Aptamers
King, D. J., Ventura, D. A., Brasier, A. R., & Gorenstein, D. G. (1998) · Biochemistry · doi:10.1021/bi981780f · Cited by 100 · see citing works
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
Denichenko, P., Mogilevsky, M., Cléry, A., Welte, T., Biran, J., Tepper, O., Barnabas, G. D., Danan-Gotthold, M., Kumar, S., Yavin, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09523-0 · Cited by 99 · see citing works
Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers
Moreno, A., Pitoc, G. A., Ganson, N. J., Layzer, J. M., Hershfield, M. S., Tarantal, A. F., & Sullenger, B. A. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.001 · Cited by 98 · see citing works
Mimicry Grasps Reality in Translation Termination
Nakamura, Y., Ito, K., & Ehrenberg, M. (2000) · Cell · doi:10.1016/s0092-8674(00)80845-4 · Cited by 97 · see citing works
Self-citationIn vitro RNA random pools are not structurally diverse: A computational analysis
Gevertz, J. L., Gan, H. H., & Tamar Schlick, A. (2005) · RNA · doi:10.1261/rna.7271405 · Cited by 94 · see citing works
Modeling, synthesis, and hybridization properties of (L)-ribonucleic acid
Ashley, G. W. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00051a001 · Cited by 94 · see citing works
MacDonald, J. P., Henri, J., Goodman, L., Xiang, D., Duan, W., & Shigdar, S. L. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00369 · Cited by 94 · see citing works
Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth
Khan, T., Weber, H., DiMuzio, J. M., Matter, A. M., Dogdas, B., Shah, T., Thankappan, A., Disa, J., Jadhav, V., Lubbers, L. S., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.55 · Cited by 90 · see citing works
Schmidt, E. G. W., Hvam, M. L., Antunes, F., Cameron, J., Viuff, D., Andersen, B., Kristensen, N. N., & Howard, K. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794248 · Cited by 85 · see citing works
Db, M., & Gb, R. (2010) · RNA: A publication of the RNA Society · doi:10.1261/rna.2242610 · Cited by 84 · see citing works
A thermostable d-polymerase for mirror-image PCR
Pech, A., Achenbach, J., Jahnz, M., Schülzchen, S., Jarosch, F., Bordusa, F., & Klußmann, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx079 · Cited by 83 · see citing works
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
Parekh, P. A., Kamble, S., Zhao, N., Zeng, Z., Portier, B. P., & Zu, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.099 · Cited by 80 · see citing works
Post-SELEX Chemical Optimization of a Trypanosome-Specific RNA Aptamer
Göringer, H. U., Adler, A., Forster, N., & Homann, M. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708783398331 · Cited by 80 · see citing works
AptaTRACE Elucidates RNA Sequence-Structure Motifs from Selection Trends in HT-SELEX Experiments
Dao, P., Hoinka, J., Takahashi, M. M., Zhou, J., Ho, M., Wang, Y., Costa, F., Rossi, J. J., Backofen, R., Burnett, J., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.07.003 · Cited by 78 · see citing works
Aptamer imaging with Cu-64 labeled AS1411: Preliminary assessment in lung cancer
Li, J., Zheng, H., Bates, P. J., Malik, T., Li, X., Trent, J. O., & Ng, C. K. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.10.008 · Cited by 77 · see citing works
Meyer, A., Garry, D., Hall, B., Byrom, M., McDonald, H. G., Yang, X., Yin, Y., & Ellington, A. D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv734 · Cited by 76 · see citing works
Architecture of high-affinity unnatural-base DNA aptamers toward pharmaceutical applications
Matsunaga, K., Kimoto, M., Hanson, C. A., Sanford, M. E., Young, H. A., & Hirao, I. (2015) · Scientific Reports · doi:10.1038/srep18478 · Cited by 76 · see citing works
Rockey, W. M., Huang, L., Kloepping, K. C., Baumhover, N. J., Giangrande, P. H., & Schultz, M. K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.010 · Cited by 75 · see citing works
Boron-containing aptamers to ATP
Lato, S. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.6.1401 · Cited by 75 · see citing works
Pegaptanib for the treatment of age-related macular degeneration
Zhou, B., & Wang, B. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.02.010 · Cited by 73 · see citing works
Nucleotide Bias Observed with a Short SELEX RNA Aptamer Library
Thiel, W. H., Bair, T., Thiel, K. W., Dassie, J. P., Rockey, W. M., Howell, C. A., Liu, X. Y., Dupuy, A. J., Huang, L., Owczarzy, R., et al. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0288 · Cited by 70 · see citing works
Thiel, W. H., Thiel, K. W., Flenker, K. S., Bair, T., Dupuy, A. J., McNamara, J. O., Miller, F. J., & Giangrande, P. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1538-5_11 · Cited by 69 · see citing works
DNA aptamer assemblies as fibroblast growth factor mimics and their application in stem cell culture
Ueki, R., Atsuta, S., Ueki, A., Hoshiyama, J., Li, J., Hayashi, Y., & Sando, S. (2019) · Chemical Communications · doi:10.1039/c8cc08080a · Cited by 69 · see citing works
Lai, W., Wang, W.-Y., Chang, Y.-C., Chang, C.-J., Yang, P., & Peck, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.054 · Cited by 67 · see citing works
In vitro selection of BNA (LNA) aptamers
Kuwahara, M., & Obika, S. (2013) · Artificial DNA PNA & XNA · doi:10.4161/adna.25786 · Cited by 67 · see citing works
In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library
Wang, H., Zhang, Y., Yang, H., Qin, M., Ding, X., Liu, R., & Jiang, Y. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.12.003 · Cited by 66 · see citing works
Decreasing miRNA sequencing bias using a single adapter and circularization approach
Barberán-Soler, S., Vo, J. M., Hogans, R. E., Dallas, A., Johnston, B. H., & Kazakov, S. A. (2018) · Genome biology · doi:10.1186/s13059-018-1488-z · Cited by 65 · see citing works
In vitro selection of phosphorothiolated aptamers
Jhaveri, S. D., Olwin, B. B., & Ellington, A. D. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00414-4 · Cited by 64 · see citing works
Yeast genetic selections to optimize RNA decoys for transcription factor NF-κB
Cassiday, L. A., & Maher, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736013100 · Cited by 62 · see citing works
Aptamers as candidate therapeutics for cardiovascular indications
Keefe, A. D., & Schaub, R. G. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.005 · Cited by 62 · see citing works
Horn, W. T., Convery, M. A., Stonehouse, N. J., ADAMS, C. J., Liljas, L., Phillips, S. E. V., & Stockley, P. G. (2004) · RNA · doi:10.1261/rna.7710304 · Cited by 62 · see citing works
In vitro selection using a dual RNA library that allows primerless selection
Jarosch, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl463 · Cited by 61 · see citing works
In silico approaches to RNA aptamer design
Hamada, M. (2017) · Biochimie · doi:10.1016/j.biochi.2017.10.005 · Cited by 58 · see citing works
Jiang, P., MEYER, S. R., Hou, Z., Propson, N. E., Soh, H. T., Thomson, J. A., & Stewart, R. M. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu348 · Cited by 57 · see citing works
Kupakuwana, G. V., Crill, J. E., McPike, M. P., & Borer, P. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019395 · Cited by 55 · see citing works
Kotula, J. W., Sun, J., Li, M., Pratico, E. D., Fereshteh, M., Ahrens, D. P., Sullenger, B. A., & Kovacs, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093441 · Cited by 51 · see citing works
Mi, J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl482 · Cited by 51 · see citing works
DNA-Aptamer Targeting Vimentin for Tumor Therapy In Vivo
Zamay, T. N., Kolovskaya, O. S., Glazyrin, Y. E., Сергеевна, З. Г., Kuznetsova, S. A., Spivak, E. A., Wehbe, M., Savitskaya, A. G., Zubkova, O. A., Kadkina, A., et al. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0471 · Cited by 51 · see citing works
Mutants of T7 RNA polymerase that are able to synthesize both RNA and DNA
Kostyuk, D. A., Dragan, S. M., Lyakhov, D. L., Rechinsky, V. O., Tunitskaya, V. L., CHERNOV, B. K., & Kochetkov, S. N. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00732-o · Cited by 49 · see citing works
Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy
Hervás‐Stubbs, S., Soldevilla, M. M., Villanueva, H., Mancheño, U., Bendandi, M., & Pastor, F. (2015) · Oncotarget · doi:10.18632/oncotarget.6608 · Cited by 49 · see citing works
Selection and characterization of anti-NF-κB p65 RNA aptamers
Wurster, S. E., & Maher, L. J. (2008) · RNA · doi:10.1261/rna.878908 · Cited by 48 · see citing works
Pan, W., & Clawson, G. A. (2009) · Molecules · doi:10.3390/molecules14041353 · Cited by 47 · see citing works
tRNA mimicry in translation termination and beyond
Nakamura, Y., & Ito, K. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.81 · Cited by 47 · see citing works
Self-citationKasahara, Y., Kitadume, S., Morihiro, K., Kuwahara, M., Ozaki, H., Sawai, H., Imanishi, T., & Obika, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.028 · Cited by 47 · see citing works
Xu, W., & Lu, Y. (2011) · Chemical Communications · doi:10.1039/c1cc10161g · Cited by 47 · see citing works
Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer’s Disease Cell Model
Liang, H., Shi, Y., Kou, Z., Peng, Y., Chen, W., Li, X., Li, S., Wang, Y., Wang, F., & Zhang, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140733 · Cited by 42 · see citing works
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
Soldevilla, M. M., Hervás, S., Villanueva, H., Lozano, T., Rabal, O., Oyarzábal, J., Lasarte, J. J., Bendandi, M., Inogés, S., de Cerio, A. L.-D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185169 · Cited by 42 · see citing works
Hirota, M., Murakami, I., Ishikawa, Y., Suzuki, T. W., Sumida, S.-I., Ibaragi, S., Kasai, H., Horai, N., Drolet, D. W., Gupta, S., et al. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0567 · Cited by 40 · see citing works
Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease
Skogen, M., Roth, J. A., Yerkes, S., Parekh‐Olmedo, H., & Kmiec, E. B. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-65 · Cited by 36 · see citing works
Maasch, C., Vater, A., Buchner, K., Purschke, W. G., Eulberg, D., Vonhoff, S., & Klußmann, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178533 · Cited by 35 · see citing works
Aminomodified Nucleobases: Functionalized Nucleoside Triphosphates Applicable for SELEX
Schoetzau, T., Langner, J., Moyroud, E., Roehl, I., Vonhoff, S., & Klußmann, S. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0256547 · Cited by 32 · see citing works
Kuhlmann, M., Hamming, J. B. R., Voldum, A., Τσακιρίδου, Γ., Larsen, M. T., Schmøkel, J. S., Sohn, E., Bieńk, K., Schaffert, D., Sørensen, E. S., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.10.004 · Cited by 32 · see citing works
Pharmacokinetic Properties of DNA Aptamers with Base Modifications
Gupta, S., Drolet, D. W., Wolk, S. K., Waugh, S. M., Rohloff, J. C., Carter, J. D., Mayfield, W. S., Otis, M. R., Fowler, C. R., Suzuki, T. W., et al. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0683 · Cited by 31 · see citing works
RNA plasticity and selectivity applicable to therapeutics and novel biosensor development
Nakamura, Y., Ishiguro, A., & Miyakawa, S. (2012) · Genes to Cells · doi:10.1111/j.1365-2443.2012.01596.x · Cited by 28 · see citing works
Self-citationA simple method for eliminating fixed‐region interference of aptamer binding during SELEX
Ouellet, E., Lagally, E. T., Cheung, K. C., & Haynes, C. A. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25294 · Cited by 27 · see citing works
Hirasawa, S., Kitahara, Y., Okamatsu, Y., Fujii, T., Nakayama, A., Ueno, S., Ijichi, C., Futaki, F., Nakata, K., & Taki, M. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00235 · Cited by 19 · see citing works
DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement
Mai, J., Li, X., Zhang, G., Huang, Y., Xu, R., Shen, Q., Lokesh, G. L.-R., Thiviyanathan, V., Chen, L., Liu, H., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01169 · Cited by 17 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Directed Evolution: Methodologies and Applications
Wang, Y., Xue, P., Cao, M., Yu, T., Lane, S., & Zhao, H. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00260 · Cited by 719 · see citing works
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05075-2 · Cited by 658 · see citing works
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 638 · see citing works
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works
Nonspecific Binding—Fundamental Concepts and Consequences for Biosensing Applications
Frutiger, A., Tanno, A., Hwu, S., Tiefenauer, R. F., Vörös, J., & Nakatsuka, N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00044 · Cited by 282 · see citing works
Aptamer–Protein Interactions: From Regulation to Biomolecular Detection
Ji, C., Wei, J., Zhang, L., Hou, X., Tan, J., Yuan, Q., & Tan, W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00377 · Cited by 220 · see citing works
Boo, Y. C. (2022) · Antioxidants · doi:10.3390/antiox11091663 · Cited by 218 · see citing works
Self-Assembling Nucleic Acid Nanostructures Functionalized with Aptamers
Krissanaprasit, A., Key, C. M., Pontula, S., & LaBean, T. H. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01332 · Cited by 183 · see citing works
Pandey, P., Khan, F., Upadhyay, T. K., Moon, S., Park, M. N., & Kim, B. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114491 · Cited by 171 · see citing works
Recent advances in quantum dots-based biosensors for antibiotics detection
Ding, R., Chen, Y., Wang, Q., Wu, Z., Zhang, X., Li, B., & Lin, L. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.08.002 · Cited by 159 · see citing works
Parihar, A., Singhal, A., Kumar, N., Khan, R., Khan, M. A., & Srivastava, A. K. (2022) · Nano-Micro Letters · doi:10.1007/s40820-022-00845-1 · Cited by 148 · see citing works
New developments in the biology of fibroblast growth factors
Ornitz, D. M., & Itoh, N. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1549 · Cited by 143 · see citing works
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation
Belgrad, J., Fakih, H. H., & Khvorova, A. (2024) · Nucleic Acid Therapeutics · doi:10.1089/nat.2023.0068 · Cited by 124 · see citing works
Generative aptamer discovery using RaptGen
Iwano, N., Adachi, T., Aoki, K., Nakamura, Y., & Hamada, M. (2022) · Nature Computational Science · doi:10.1038/s43588-022-00249-6 · Cited by 122 · see citing works
Self-citationCurrent State of Human Gene Therapy: Approved Products and Vectors
Shchaslyvyi, A. Y., Antonenko, S. V., Tesliuk, M. G., & Телегеев, Г. Д. (2023) · Pharmaceuticals · doi:10.3390/ph16101416 · Cited by 120 · see citing works
Sanadgol, N., Abedi, M., Hashemzaei, M., Kamran, Z., Khalseh, R., Beyer, C., & Voelz, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03528-2 · Cited by 109 · see citing works
Non-canonical DNA structures: Diversity and disease association
Bansal, A., Kaushik, S., & Kukreti, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.959258 · Cited by 106 · see citing works
Aptamer-Targeted Photodynamic Platforms for Tumor Therapy
Yan, J., Gao, T., Lu, Z., Yin, J., Zhang, Y., & Pei, R. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c06818 · Cited by 104 · see citing works
Takakusa, H., Iwazaki, N., Nishikawa, M., Yoshida, T., Obika, S., & Inoué, T. (2023) · Nucleic Acid Therapeutics · doi:10.1089/nat.2022.0054 · Cited by 102 · see citing works
Chemistry of Peptide-Oligonucleotide Conjugates: A Review
Klabenkova, K., Фокина, А. А., & Stetsenko, D. A. (2021) · Molecules · doi:10.3390/molecules26175420 · Cited by 100 · see citing works
Riccardi, C., Napolitano, E., Platella, C., Musumeci, D., & Montesarchio, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107649 · Cited by 94 · see citing works
The Application of Nanomaterials for the Electrochemical Detection of Antibiotics: A Review
Alsaiari, N. S., Katubi, K. M., Alzahrani, F. M. A., Siddeeg, S. M., & Tahoon, M. A. (2021) · Micromachines · doi:10.3390/mi12030308 · Cited by 87 · see citing works
Biomedical Applications of Metal–Organic Frameworks Revisited
Sezgin, P., Gulcay-Ozcan, E., Vučkovski, M., Bondžić, A. M., Eruçar, İ., & Keskın, S. (2025) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.4c03698 · Cited by 87 · see citing works
Oliva, N., & Almquist, B. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.021 · Cited by 80 · see citing works
Photoresponsive Drug Delivery Systems: Challenges and Progress
Yang, Y., Long, K., Chu, Y., Lu, H., Wang, W., & Zhan, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402975 · Cited by 75 · see citing works
RNA Therapeutics - Research and Clinical Advancements
Feng, R., Patil, S., Zhao, X., Miao, Z., & Qian, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.710738 · Cited by 73 · see citing works
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
Camorani, S., Passariello, M., Agnello, L., Esposito, S., Collina, F., Cantile, M., Bonito, M. D., Ulasov, I. V., Fedele, M., Zannetti, A., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01694-9 · Cited by 72 · see citing works
Ali, G. K., & Omer, K. M. (2022) · ACS Omega · doi:10.1021/acsomega.2c05232 · Cited by 66 · see citing works
Cell Surface Engineering Tools for Programming Living Assemblies
Almeida-Pinto, J., Lagarto, M. R., Lavrador, P., Mano, J. F., & Gaspar, V. M. (2023) · Advanced Science · doi:10.1002/advs.202304040 · Cited by 66 · see citing works
Electrochemical aptasensors for clinical diagnosis. A review of the last five years
Villalonga, A., Mayol, B., Villalonga, R., & Vilela, D. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132318 · Cited by 62 · see citing works
Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., Fathi‐karkan, S., Mirinejad, S., Sargazi, S., Sheervalilou, R., Ajalli, N., et al. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04614-x · Cited by 61 · see citing works
Chinnappan, R., Mir, T. A., Alsalameh, S., Makhzoum, T., Adeeb, S., AlKattan, K. M., & Yaqinuddin, A. (2023) · Life · doi:10.3390/life13061273 · Cited by 61 · see citing works
Aptamer-Based Point-of-Care Devices: Emerging Technologies and Integration of Computational Methods
Aslan, Y., Atabay, M., Chowdhury, H. K., Göktürk, I., Saylan, Y., & İnci, F. (2023) · Biosensors · doi:10.3390/bios13050569 · Cited by 58 · see citing works
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition
Riccardi, C., Napolitano, E., Musumeci, D., & Montesarchio, D. (2020) · Molecules · doi:10.3390/molecules25225227 · Cited by 55 · see citing works
Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer
Sanjanwala, D., & Patravale, V. B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103550 · Cited by 55 · see citing works
Kumar, S., Mohan, A., Sharma, N. R., Kumar, A., Girdhar, M., Malik, T., & Verma, A. K. (2024) · ACS Omega · doi:10.1021/acsomega.4c02466 · Cited by 55 · see citing works
Overcoming Challenges in Electrochemical Sensing: Toward Continuous Monitoring
Rivera, P., Pelle, F. D., Stonyte, J., Melo, W., Abouhagger, A., & Pauliukaitė, R. (2025) · ACS Sensors · doi:10.1021/acssensors.5c02717 · Cited by 55 · see citing works
Organic Electrochemical Transistor Aptasensor for Interleukin-6 Detection
Diacci, C., Burtscher, B., Berto, M., Ruoko, T., Lienemann, S., Greco, P., Magnus Berggren, A., Borsari, M., Simon, D. T., Bortolotti, C. A., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12397 · Cited by 53 · see citing works
Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors
Liu, M., Zaman, K., & Fortenberry, Y. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083897 · Cited by 53 · see citing works
Oligonucleotide aptamers for pathogen detection and infectious disease control
Wan, Q., Liu, X., & Zu, Y. (2021) · Theranostics · doi:10.7150/thno.61804 · Cited by 51 · see citing works
DNA‐Based Dissipative Assembly toward Nanoarchitectonics
Liu, Q., Li, H., Yu, B., Meng, Z., Zhang, X., Li, J., & Zheng, L. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202201196 · Cited by 50 · see citing works
Advances in Design Strategies of Multiplex Electrochemical Aptasensors
Grabowska, I., Hepel, M., & Kurzątkowska, K. (2021) · Sensors · doi:10.3390/s22010161 · Cited by 49 · see citing works
Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review
Ravichandran, G., & Rengan, A. K. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01785 · Cited by 47 · see citing works
Novel formulations and drug delivery systems to administer biological solids
Zhang, Y., Davis, D. A., AboulFotouh, K., Wang, J., Williams, D., Bhambhani, A., Zakrewsky, M., Maniruzzaman, M., Cui, Z., & Williams, R. O. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.011 · Cited by 47 · see citing works
Recent progress in the early detection of cancer based on CD44 biomarker; nano-biosensing approaches
Kazemi, Y., Dehghani, S., Nosrati, R., Taghdisi, S. M., Abnous, K., Alibolandi, M., & Ramezani, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120593 · Cited by 47 · see citing works
Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation
Yan, J., Li, T., Miao, Z., Wang, P., Sheng, C., & Zhuang, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00728 · Cited by 44 · see citing works
RNA-binding proteins as therapeutic targets in cancer
Jungfleisch, J., & Gebauer, F. (2025) · RNA Biology · doi:10.1080/15476286.2025.2470511 · Cited by 42 · see citing works
Sforzi, J., Palagi, L., & Aime, S. (2020) · Biology · doi:10.3390/biology9080202 · Cited by 42 · see citing works
Synthetic and Biogenic Materials for Oral Delivery of Biologics: From Bench to Bedside
Ding, S., Alexander, E., Liang, H., Kulchar, R. J., SINGH, R. K., Herzog, R. W., Daniell, H., & Leong, K. W. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00482 · Cited by 42 · see citing works
Cornea‐SELEX for aptamers targeting the surface of eyes and liposomal drug delivery
Wong, K., Liu, Y., Wong, M., & Liu, J. (2024) · Exploration · doi:10.1002/exp.20230008 · Cited by 40 · see citing works
Roushani, M., & Zalpour, N. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106955 · Cited by 39 · see citing works
Bege, M., Kattoub, R. G., & Borbás, A. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030394 · Cited by 38 · see citing works
Aptamer-based targeted drug delivery and disease therapy in preclinical and clinical applications
Yang, W., Ran, C., Lian, X., Wang, Z., Du, Z., Bing, T., Zhang, Y., & Tan, W. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115680 · Cited by 37 · see citing works
Jahangiri–Dehaghani, F., Zare, H. R., & Shekari, Z. (2021) · Food Analytical Methods · doi:10.1007/s12161-021-02109-x · Cited by 37 · see citing works
Hosseini-Kharat, M., Bremmell, K. E., Grubor‐Bauk, B., & Prestidge, C. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.002 · Cited by 36 · see citing works
Electrochemical Aptasensors Based on Hybrid Metal-Organic Frameworks
Evtugyn, G. A., Belyakova, S. V., Porfireva, A. V., & Hianik, T. (2020) · Sensors · doi:10.3390/s20236963 · Cited by 36 · see citing works
Inam, A. K. M. S., Angeli, M. A. C., Douaki, A., Shkodra, B., Lugli, P., & Petti, L. (2022) · Sensors · doi:10.3390/s22072754 · Cited by 36 · see citing works
Recent advances in aptamer-based platforms for cortisol hormone monitoring
Mohammadi, F., Zahraee, H., Kazemi, M., Habibi, Z. S., Taghdisi, S. M., Abnous, K., Khoshbin, Z., & Chen, C. (2023) · Talanta · doi:10.1016/j.talanta.2023.125010 · Cited by 35 · see citing works
Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
Amero, P., Khatua, S., Rodriguez‐Aguayo, C., & Lopez‐Berestein, G. (2020) · Cancers · doi:10.3390/cancers12102889 · Cited by 35 · see citing works
Aptamer-based Theranostics in Oncology: Design Strategies and Limitations
Trivedi, J., Yasir, M., Maurya, R. K., & Tripathi, A. S. (2024) · BIO Integration · doi:10.15212/bioi-2024-0002 · Cited by 34 · see citing works
Truncations and in silico docking to enhance the analytical response of aptamer-based biosensors
Nguyen, M., Osborne, M., Prevot, G. T., Churcher, Z. R., Johnson, P. E., Simine, L., & Dauphin‐Ducharme, P. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116680 · Cited by 34 · see citing works
Harnessing synthetic biology for advancing RNA therapeutics and vaccine design
Pfeifer, B. A., Beitelshees, M., Hill, A. B., Bassett, J., & Jones, C. H. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00323-3 · Cited by 33 · see citing works
Decoding aptamer-protein binding kinetics for continuous biosensing using single-molecule techniques
Filius, M., Fasching, L., van Wee, R., Rwei, A. Y., & Joo, C. (2025) · Science Advances · doi:10.1126/sciadv.ads9687 · Cited by 33 · see citing works
Cortisol sensing by optical sensors
Santonocito, R., Puglisi, R., Cavallaro, A., Pappalardo, A., & Sfrazzetto, G. T. (2023) · The Analyst · doi:10.1039/d3an01801f · Cited by 32 · see citing works
Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells
Li, Z., Fu, X., Huang, J., Zeng, P., Huang, Y., Chen, X., & Liang, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.662791 · Cited by 32 · see citing works
Recent advances of cell surface modification based on aptamers
Jia, H., Zhang, Z., Fang, X., Jiang, M., Chen, M., Chen, S., Gu, K., Luo, Z., Wu, F., & Tan, W. (2022) · Materials Today Nano · doi:10.1016/j.mtnano.2022.100188 · Cited by 32 · see citing works
Growth hormone-releasing hormone and its analogues in health and disease
Granata, R., Leone, S., Zhang, X., Gesmundo, I., Steenblock, C., Cai, R., Sha, W., Ghigo, E., Hare, J. M., Bornstein, S. R., et al. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01052-1 · Cited by 31 · see citing works
Chimeric antigen receptor Treg therapy in transplantation
Eskandari, S. K., Daccache, A., & Azzi, J. R. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.11.005 · Cited by 30 · see citing works
Methods to study circRNA-protein interactions
Ulshöfer, C. J., Pfafenrot, C., Bindereif, A., & Schneider, T. P. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.014 · Cited by 30 · see citing works
Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy
Bayani, A., Abosaoda, M. K., Rizaev, J. A., Nazari, M., Jafari, Z., & Samarkhazan, H. S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01724-w · Cited by 29 · see citing works
Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases
Chen, X., Zhao, X., & Yang, Z. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01567 · Cited by 29 · see citing works
Aptamers: precision tools for diagnosing and treating infectious diseases
Sujith, S., Naresh, R., Srivisanth, B. U., Sajeevan, A., Rajaramon, S., David, H., & Solomon, A. P. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1402932 · Cited by 28 · see citing works
Tabuchi, Y., Yang, J., & Taki, M. (2021) · Chemical Communications · doi:10.1039/d0cc08109d · Cited by 28 · see citing works
Oligonucleotide-Based Therapies for Renal Diseases
Cartón‐García, F., Saande, C. J., Meraviglia-Crivelli, D., Aldabe, R., & Pastor, F. (2021) · Biomedicines · doi:10.3390/biomedicines9030303 · Cited by 28 · see citing works
Cui, J., Zhang, Y., Kan, L., Wu, B., He, L., Wang, M., Fang, S., Zhang, Z., & Zhou, L. (2023) · Microchimica Acta · doi:10.1007/s00604-023-05978-7 · Cited by 28 · see citing works
Hu, Y., Wang, Z., Liu, L., Zhu, J., Zhang, D., Xu, M., Zhang, Y., Xu, F., & Chen, Y. (2021) · Chemical Science · doi:10.1039/d1sc00271f · Cited by 27 · see citing works
Jang, S. J., & Kim, T. H. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116039 · Cited by 26 · see citing works
Effects of Experimental Conditions on the Signaling Fidelity of Impedance-Based Nucleic Acid Sensors
Vogiazi, V., de la Cruz, A., Heineman, W. R., White, R. J., & Dionysiou, D. D. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03269 · Cited by 26 · see citing works
Zhang, W., Wang, J., & Shan, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107195 · Cited by 25 · see citing works
Aptamer and Oligonucleotide-Based Biosensors for Health Applications
Mayol, B., Qubbaj, I. Z., Nava-Granados, J., Vasquez, K., Keene, S. T., & Sempionatto, J. R. (2025) · Biosensors · doi:10.3390/bios15050277 · Cited by 25 · see citing works
Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach
Vi, C., Mandarano, G., & Shigdar, S. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116163 · Cited by 25 · see citing works
Alamudi, S. H., Kimoto, M., & Hirao, I. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00199j · Cited by 25 · see citing works
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
Agnello, L., d’Argenio, A., Nilo, R., Fedele, M., Camorani, S., & Cerchia, L. (2023) · Cancers · doi:10.3390/cancers15072010 · Cited by 25 · see citing works
Repurposing CRISPR/Cas to Discover SARS‐CoV‐2 Detecting and Neutralizing Aptamers
Zhang, J., Zhu, A., Mei, M., Qu, J. T., Huang, Y., Shi, Y., Xue, M., Zhang, J., Zhang, R., Zhou, B., et al. (2023) · Advanced Science · doi:10.1002/advs.202300656 · Cited by 25 · see citing works
Switchable DNA Catalysts for Proximity Labeling at Sites of Protein–Protein Interactions
Ogorek, A. N., Zhou, X., & Martell, J. D. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c05578 · Cited by 25 · see citing works
Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy
Zhang, J., Wang, F., Sun, Z., Ye, J., & Chu, H. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03236-x · Cited by 24 · see citing works
Recent Progress on Highly Selective and Sensitive Electrochemical Aptamer-based Sensors
Tang, T., Liu, Y., & Jiang, Y. Y. (2022) · Chemical Research in Chinese Universities · doi:10.1007/s40242-022-2084-z · Cited by 24 · see citing works
Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model
Lin, Q., Leng, Y., Zhu, X., Tang, M., Lin, Y., Luo, W., Jiang, B., Chen, X., & Xie, L. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.05.02 · Cited by 24 · see citing works
Kukushkin, V. I., Kristavchuk, O. V., Andreev, E. V., Meshcheryakova, N. F., Zaborova, O. V., Gambaryan, A. S., Nechaev, A. N., & Zavyalova, E. G. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1076749 · Cited by 24 · see citing works
Aptamers as target-specific recognition elements in drug delivery
Vydaline, A. O. E., Rozhkov, S., Sosa, G., & Mallikaratchy, P. R. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115685 · Cited by 23 · see citing works
Ayupova, T., Shaimerdenova, M., Sypabekova, M., Vangelista, L., & Tosi, D. (2021) · Optik · doi:10.1016/j.ijleo.2021.166969 · Cited by 23 · see citing works
Recent Advances in DNA Nanotechnology for Plasmonic Biosensor Construction
Park, J. A., Amri, C., Kwon, Y., Lee, J., & Lee, T. (2022) · Biosensors · doi:10.3390/bios12060418 · Cited by 23 · see citing works
Murray, M. T., & Wetmore, S. D. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae729 · Cited by 23 · see citing works
Designing a new dimerized anti human TNF‐α aptamer with blocking activity
Mashayekhi, K., Ganji, A., & Sankian, M. (2020) · Biotechnology Progress · doi:10.1002/btpr.2969 · Cited by 23 · see citing works
Rezapoor-Fashtali, Z., Ganjali, M. R., & Faridbod, F. (2022) · Biosensors · doi:10.3390/bios12090720 · Cited by 22 · see citing works
Guzman, N. A., & Guzman, D. E. (2020) · Biomedicines · doi:10.3390/biomedicines8080255 · Cited by 22 · see citing works
Relative Nuclease Resistance of a DNA Aptamer Covalently Conjugated to a Target Protein
Tabuchi, Y., Yang, J., & Taki, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147778 · Cited by 21 · see citing works
Advances in RNA cancer therapeutics: New insight into exosomes as miRNA delivery
Volpini, L., Monaco, F., Santarelli, L., Neužil, J., & Tomasetti, M. (2023) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2023.100005 · Cited by 21 · see citing works
A capacitive laser-induced graphene based aptasensor for SARS-CoV-2 detection in human saliva
Moreira, G. A. M., Qian, H., Datta, S., Bliznyuk, N., Carpenter, J., Dean, D. M. D., McLamore, E. S., & Vanegas, D. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290256 · Cited by 21 · see citing works
Advancements in magnetic aptasensors: Recent progress and future trends in biosensor technology
Behyar, M. B., Nilghaz, A., Ebrahimi, R., Hasanzadeh, M., & Shadjou, N. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117549 · Cited by 21 · see citing works
- Authors
- Adachi, T., & Nakamura, Y.
- Affiliations
- RIBOMIC Inc., Minato-ku, Tokyo 108-0071, Japan
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Adachi, Tatsuo
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-11-21
- Volume
- 24
- Issue
- 23
- Pages
- 4229
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6930564
- OpenAlex
- W2989998401
- Cited by
- 300
- References
- 115
- Citations by year
- 2026: 33 · 2025: 50 · 2024: 59 · 2023: 53 · 2022: 44 · 2021: 42 · 2020: 19
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Tokyo
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- aptamers, aptamer therapeutics, chemical modification, oligonucleotide chemistry, pegaptanib, vascular endothelial growth factor, age-related macular degeneration, drug delivery
- MeSH terms
- Animals, Humans, Infections, Neoplasms, Aptamers, Nucleotide, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review